Gavin P. Dunn

Also affiliated with Harvard University, Massachusetts General Hospital, Mass General Brigham

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Papers

Driven by 35 papers — median percentile 0. Top paper: “Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial”.

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1695

N/A

7.0DataRank · unranked

368 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine

Neuro-Oncology(2020)10.1093/neuonc/noaa050

N/A

0DataRank · unranked

80 citations

Maximilian O. Schaettler, Dylan T. Blaha, Jay A. Bowman-Kirigin, Dale K. Kobayashi, Alexandra J. Livingstone +6 more

Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy

Neuro-Oncology(2020)10.1093/neuonc/noaa154

N/A

0DataRank · unranked

57 citations

Timothy F. Cloughesy, Marcela V. Maus, Robert M. Prins, David A. Reardon, Adam M. Sonabend +1 more

Cancers from Novel Pole -Mutant Mouse Models Provide Insights into Polymerase-Mediated Hypermutagenesis and Immune Checkpoint Blockade

Cancer Research(2020)10.1158/0008-5472.can-20-0624

N/A

0DataRank · unranked

25 citations

Karl P. Hodel, Miki S. Gams, Sumedha Sudhaman, Taylor Bridge, Walter J. Zahurancik +31 more

TERT, a promoter of CNS malignancies

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa025

N/A

0DataRank · unranked

40 citations

Rukayat Taiwo, Albert H. Kim, Gavin P. Dunn, Bhuvic Patel

GATA2 Regulates Constitutive PD-L1 and PD-L2 Expression in Brain Tumors

Scientific Reports(2020)10.1038/s41598-020-65915-z

N/A

0DataRank · unranked

24 citations

Connor J. Liu, Dale K. Kobayashi, Tanner M. Johanns, Jay A. Bowman-Kirigin, Maximilian O. Schaettler +11 more

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial

medRxiv(2020)10.1101/2020.03.18.20037846

N/A

0DataRank · unranked

4 citations

Katie M. Campbell, Ann Marie Egloff, Paul Zolkind, Zachary L. Skidmore, Brian Nussenbaum +39 more

Computational prediction of MHC anchor locations guide neoantigen identification and prioritization

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.08.416271

N/A

0DataRank · unranked

1 citations

Joshua F. McMichael, Michelle Becker‐Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain +20 more

Sonobiopsy for minimally invasive, spatiotemporally-controlled, and sensitive detection of glioblastoma-derived circulating tumor DNA

Theranostics(2021)10.7150/thno.65597

N/A

0DataRank · unranked

72 citations

Jinyun Yuan, Yimei Yue, Lu Xu, Arash Nazeri, Rupen Desai +8 more

Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0291

N/A

0DataRank · unranked

71 citations

Megan M. Richters, Anthony Z. Wang, Zachary L. Skidmore, Bryan Fisk, Katherine E. Miller +15 more

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation

Genome Medicine(2021)10.1186/s13073-021-00872-4

N/A

0DataRank · unranked

67 citations

Xiuli Zhang, Xiaoli Wang, Samuel W. Kim, John M. Herndon, Michelle Becker‐Hapak +13 more

Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma

Nature Communications(2021)10.1038/s41467-021-26653-6

N/A

0DataRank · unranked

61 citations

Bhuvic Patel, Hao Chen, Patrick DeSouza, Xuan Qu, Diane D. Mao +12 more

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-4179

N/A

0DataRank · unranked

41 citations

Katie M. Campbell, Jason A. Webb, Paul Zolkind, Zachary L. Skidmore, Rachel Riley +10 more

Single Cell Atlas of Human Dura Reveals Cellular Meningeal Landscape and Insights into Meningioma Immune Response

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.03.454066

N/A

0DataRank · unranked

4 citations

Jay A. Bowman-Kirigin, Rupen Desai, Pujan R. Patel, Bhuvic Patel, Saad M. Khan +12 more

The conventional dendritic cell 1 subset primes CD8 + T cells and traffics tumor antigen to drive anti-tumor immunity in the brain

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.13.460088

N/A

0DataRank · unranked

2 citations

Brian T. Saunders, Rupen Desai, Anthony Z. Wang, Max Schaettler, Connor J. Liu +14 more

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac185

N/A

0DataRank · unranked

76 citations

Ambike Aarti Srivastava, Rishab Ramapriyan, Stefanie R. Bailey, Amanda A. Bouffard, Daniel P. Cahill +17 more

The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0098

N/A

0DataRank · unranked

48 citations

Rupen Desai, Brian T. Saunders, Anthony Z. Wang, Maximilian O. Schaettler, Connor J. Liu +14 more

Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-4064

N/A

0DataRank · unranked

44 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm

Neurosurgical FOCUS(2022)10.3171/2022.8.focus22367

N/A

0DataRank · unranked

17 citations

Andrew T. Coxon, Jiayi Huang, Christopher Abraham, Joshua L. Dowling, Eric C. Leuthardt +8 more

Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac002

N/A

0DataRank · unranked

10 citations

Yu Tao, Jingqin Luo, Mounica Paturu, Hsiang‐Chih Lu, Shakti Ramkissoon +10 more

A Low Subfrontal Dural Opening for Operative Management of Anterior Skull Base Lesions

Journal of Neurological Surgery Part B Skull Base(2022)10.1055/a-1774-6281

N/A

0DataRank · unranked

1 citations

Gavin P. Dunn, Gregory J. Zipfel, Ralph G. Dacey, Michael R. Chicoine, Samuel J. Cler

503 Cytotoxic revival is implicated in response to neoadjuvant PD-1 blockade for head and neck squamous cell carcinoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0503

N/A

0DataRank · unranked

2 citations

Giacomo Oliveira, Ann Marie Egloff, Zexiang Zeng, Rebecca D. Chernock, Liye Zhou +33 more

Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

Nature Communications(2023)10.1038/s41467-023-37266-6

N/A

0DataRank · unranked

131 citations

Yang-Yang Feng, Avinash Ramu, Megan M. Richters, Sharon L. Freshour, Zachary L. Skidmore +19 more

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer

Science Immunology(2023)10.1126/sciimmunol.adf4968

N/A

0DataRank · unranked

118 citations

Ann Marie Egloff, Alexander B. Afeyan, Jacquelyn O. Wolff, Zexiang Zeng, Rebecca D. Chernock +34 more

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

Nature Communications(2023)10.1038/s41467-023-36878-2

N/A

0DataRank · unranked

47 citations

Junfei Zhao, Li Chen, Andrew Gould, Brandyn Castro, Víctor A. Arrieta +22 more

Computational prediction of MHC anchor locations guides neoantigen identification and prioritization

Science Immunology(2023)10.1126/sciimmunol.abg2200

N/A

0DataRank · unranked

27 citations

Joshua F. McMichael, Michelle Becker‐Hapak, Onyinyechi C. Onyeador, Rico Buchli, Ethan McClain +20 more

TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006121

N/A

0DataRank · unranked

18 citations

Rupen Desai, Anthony Z. Wang, Alexandra J. Livingstone, Dale K. Kobayashi, Andrew T. Coxon +9 more

Glioblastoma-infiltrating CD8 + T cells are predominantly a clonally expanded GZMK + effector population

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.25.554678

N/A

0DataRank · unranked

2 citations

Bryce L. Mashimo, Maximilian O. Schaettler, Ngima D. Sherpa, Lydia A. Leavitt, Alexandra J. Livingstone +16 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6532395.v1

Top 100%

0DataRank

Top 100%0 citations

Nathan Standifer, Jörg Dietrich, Jennifer Clarke, Gavin P. Dunn, Michael Lim +21 more

Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3077

N/A

0DataRank · unranked

27 citations

Elizabeth A.R. Garfinkle, Katherine E. Miller, Alexandra J. Livingstone, Kaleigh F. Roberts, Lakshmi P. Rao Venkata +8 more

Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastoma

Neuro-Oncology(2024)10.1093/neuonc/noae073

N/A

0DataRank · unranked

19 citations

William J. Smith, Joseph D. Bradley, Eric Esposito, Mihir Gupta, Evan Burns +19 more

Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity

Molecular Therapy(2025)10.1016/j.ymthe.2025.08.028

N/A

0DataRank · unranked

4 citations

Lisa Nieland, Sanne M. van de Looij, Alexandra J E M de Reus, Charles Couturier, Chadi A. El Farran +19 more

Immunotherapy and targeted therapy for high grade gliomas: current and future directions

Journal of Neuro-Oncology(2025)10.1007/s11060-025-05315-3

N/A

0DataRank · unranked

1 citations

Samuel J. Steuart, Angel O. Odukoya, Briana C. Prager, Young Joon Kim, Cameron Hill +3 more

Targeting myeloid cell polarization to prevent GBM recurrence

Molecular Therapy(2025)10.1016/j.ymthe.2025.12.019

N/A

0DataRank · unranked

0 citations

Gavin P. Dunn, Ralph Weissleder, Christopher Garris

Gavin P. Dunn

Indexed papers

Top data-sharing exemplar

Papers